2018 US HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs

Complete report $2,300.  DataPack (test volumes, sales forecasts, supplier shares) $1,500.

Summary

This report presents detailed analyses of the AIDS diagnostics market in the US.  The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot,
HTLV-I/II
and other confirmatory tests performed in the following market segments:

     - Hospitals
     - Commercial/Private Laboratories
     - Blood Banks
     - Physician Offices
     - Public Health Laboratories

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments.  The database contains information on companies, technologies, products and executives worldwide.  Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 250 pages and 6 tables

I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. USA: Market Size, Growth and Major Suppliers
Sales and Market Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech /Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List Of Tables

Major Companies Developing or Marketing AIDS Tests

USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

USA: HIV Ag Test Volume and Sales Forecasts
By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales

USA: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment

USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers



South Africa Clinical Chemistry and Immunodiagnostic Markets 2018-2023: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities for Suppliers

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five

USD 3750 View Report

Nigeria Clinical Chemistry and Immunodiagnostic Markets 2018-2023: Volume and Sales Segment Forecasts for Routine and Special Chemistries, Endocrine Function, Immunoproteins, TDM, and Tumor Markers--Competitive Strategies, Opportunities for Suppliers

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five

USD 3750 View Report

US HIV/AIDS Molecular and Immunodiagnostics Market, 2019-2023: Supplier Country Shares, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs

This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and

USD 1850 View Report

US HIV/AIDS Diagnostics Market Shares and Segment Forecasts 2023: HIV 1/2, Combo, Ag, NAT, Western Blot

This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:    - Hospitals    -

USD 900 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available